Oncology Strategy Board

We have taken the initiative to intensify the conduct of outpatient studies in the field of oncology in order to make new therapy options available to as many patients as possible. Together with our Oncology Strategy Board, we want to sustainably promote outpatient oncology trials in Germany. Here is an overview of our Oncology Strategy Board Members with brief information on medical expertise and career highlights.

Here you can find an overview of our Oncology Strategy Board members with brief information about their medical expertise and background.


MD. Jens-Joachim Brücher
MD. Lars Fechner
MD. Hendrik Kröning
MD. Nicolas Leitz
Prof. Dr. Hartmut Link
Prof. Dr. med. Dr. PhD. Sven Quist
Dr. Robert Scheuerlein